BioNeutra Global Corp. | Income Statement
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
15,672.40
16,044.50
25,990.60
32,142.40
37,717.10
Cost of Goods Sold (COGS) incl. D&A
-
9,490.80
10,776.20
20,401.60
29,186.70
31,853.50
Gross Income
-
6,181.60
5,268.40
5,589.00
2,955.70
5,863.60
SG&A Expense
59.20
2,629.70
4,677.70
2,910.10
3,019.80
3,464.70
EBIT
59.20
3,551.90
590.70
2,678.90
64.10
2,398.80
Unusual Expense
-
804.60
86.60
-
393.00
116.80
Non Operating Income/Expense
17.10
167.30
377.20
107.30
952.20
1,612.30
Interest Expense
-
24.00
176.00
476.00
518.80
563.90
Pretax Income
42.00
2,921.10
913.40
2,155.70
1,079.30
3,572.60
Income Tax
-
2,189.30
733.90
1,076.10
81.60
469.60
Consolidated Net Income
42.00
5,110.40
179.50
1,079.60
1,160.90
3,103
Net Income
42.00
5,110.40
179.50
1,079.60
1,160.90
3,103
Net Income After Extraordinaries
42.00
5,110.40
179.50
1,079.60
1,160.90
3,103
Net Income Available to Common
42.00
5,110.40
179.50
1,079.60
1,160.90
3,103
EPS (Basic)
0.00
-
0.00
0.02
0.03
0.07
Basic Shares Outstanding
11,926.00
24,033.80
45,058.40
45,949.80
45,949.80
45,949.80
EPS (Diluted)
0.00
0.21
0.00
0.02
0.03
0.07
Diluted Shares Outstanding
11,926.00
24,033.80
45,524.40
46,681.60
45,949.80
46,361.30
EBITDA
59.20
3,701.20
1,418.20
3,852.50
1,065.80
3,375.30
Non-Operating Interest Income
0.10
30.60
34.90
19.70
21.20
8.60
About BioNeutra Global
View Profile
